Non-Medical Switching

Summit on Biologics and Biosimilars Tackles Choice, Switching & Patient Access

April 10, 2017

Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the best choice.  This opening thought from Alliance for Patient Access Chairman David Charles, MD, set the tone for the organization’s second annual National Policy and Advocacy Summit on Biologics and Biosimilars, held Thursday in Washington, DC.

New IfPA Data Support Non-Medical Switching Concerns

October 12, 2016

Preliminary data from the Institute for Patient Access suggest what opponents of non-medical switching have long suspected: having medications switched for financial reasons could be bad news for patients with chronic diseases.